Insider trades

Barry Ticho, Chief Officer of Stoke Therapeutics STOK, has filed 0 purchases and 60 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/01.

Barry Ticho

Chief Medical Officer
First filing
23/02/02
Trades
118 trades
Buys / sales
0 / 60
12-month net buying
−$1.2M
Last trade
06/01

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/0106/031,795 sh$30.58$54,891.1−4.9%
Open-market sale10b5-1 plan05/0105/052,243 sh$32.79$73,547.97−5.8%
Open-market sale10b5-1 plan04/0104/031,838 sh$32.66$60,029.08−4.5%
STOK
Open-market sale10b5-1 plan03/17–03/1903/1914,311 sh6 trades$31.92avg.$456,826.55−26.0%
STOK
Open-market sale10b5-1 plan25/12/04–25/12/0525/12/055,358 sh4 trades$31.19avg.$167,120.08−21.3%
STOK
Open-market sale25/12/02–25/12/0325/12/034,020 sh4 trades$30.22avg.$121,468.83−21.0%
STOK
Open-market sale10b5-1 plan25/11/0325/11/055,931 sh4 trades$25.72avg.$152,548.82−45.2%
Open-market sale10b5-1 plan25/10/0125/10/035,343 sh$23.64$126,308.52−28.9%
Open-market sale10b5-1 plan25/09/0225/09/035,501 sh$19.87$109,304.87−22.9%
Open-market sale25/08/1825/08/202,805 sh$18.24$51,163.2−10.5%
Open-market sale10b5-1 plan25/08/0125/08/054,504 sh$12.82$57,741.28−21.2%
Open-market sale10b5-1 plan25/07/0125/07/024,503 sh$11.63$52,369.89−17.5%
STOK
Open-market sale10b5-1 plan25/06/02–25/06/0325/06/048,216 sh2 trades$10.02avg.$82,354.13−24.2%
STOK
Open-market sale10b5-1 plan25/05/01–25/05/0225/05/0526,631 sh2 trades$10.03avg.$266,993.7−43.9%
STOK
Open-market sale25/03/18–25/03/1925/03/207,217 sh2 trades$8.49avg.$61,238.19−10.6%
Open-market sale24/12/0924/12/112,586 sh$12.99$33,592.14−5.5%
Open-market sale24/12/0624/12/1013,945 sh$12.78$178,217.1−22.8%
Open-market sale10b5-1 plan24/12/0224/12/0310,000 sh$12.07$120,700−16.3%
Open-market sale10b5-1 plan24/11/0124/11/0510,000 sh$12.68$126,800−80.1%
Open-market sale10b5-1 plan24/10/0124/10/0210,000 sh$12.06$120,600−80.1%